Edit |   |
---|---|
Antigenic Specificity | CD137, Human (Utomilumab biosimilar) |
Clone | Utomilumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, FCM, IP, IF, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD137 Recombinant Antibody (Utomilumab). Utomilumab (PF-05082566) targets this receptor to stimulate a more intense immune system attack on cancers. It is a fully human IgG2 monoclonal antibody. It is in early clinical trials. As of June 2016 5 clinical trials are active. |
Immunogen | n/a |
Other Names | Anti-CD137 Recombinant Antibody, Research Grade Utomilumab, Anti-Human CD137 Recombinant Antibody(Utomilumab), PF-05082566, PF-2566, Antibody Drug Analogues, Monoclonal Antibody, YR1434, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1417318-27-4 |
Catalog # | YR1434 |
Price | please inquire |
Order / More Info | CD137, Human (Utomilumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |